LABD Stock Summary and Trading Ideas (Direxion Daily S&P Biotech Bear 3X | ARCA:LABD)

The Fund seeks daily investment results, before fees and expenses, of 300% of the inverse (or opposite) of the performance of the S&P Biotechnology Select Industry Index. The Index is provided by Standard & Poor s and includes domestic companies from the biotechnology industry. As of April 30, 2015, the Index was comprised of 98 stocks. The companies included in the Index have a median market capitalization of $1.54 billion and are concentrated in the energy and biotechnology sectors as of April 30, 2015.

Direxion Daily S&P Biotech Bear 3X trades on the ARCA stock market under the symbol LABD.

As of December 12, 2024, LABD stock price climbed to $6.51 with 21,011,547 million shares trading.

LABD has a beta of -3.88, meaning it tends to be less sensitive to market movements. LABD has a correlation of 0.32 to the broad based SPY ETF.

LABD has a market cap of $78.22 million. This is considered a Micro Cap stock.

In the last 3 years, LABD traded as high as $85.28 and as low as $4.78.

LABD has underperformed the market in the last year with a return of -53.9%, while SPY returned +32.5%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in LABD shares. However, LABD has outperformed the market in the last 3 month and 2 week periods, returning +11.7% and +18.6%, while SPY returned +9.4% and +1.0%, respectively. This indicates LABD has been having a stronger performance recently.

LABD support price is $5.72 and resistance is $6.32 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that LABD shares will trade within this expected range on the day.